Karima Redouan
Family · Clearwater, FLNPI 1770090623
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $106.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Abbott$764
- Novo Nordisk$547
- Dexcom, Inc.$535
- AstraZeneca$514
- Abiomed$502
- plus $5K from 28 others
What the payments were for
- Food & beverage$9,183100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $1,370 |
| Abbott | 7 | $764 |
| Novo Nordisk | 5 | $547 |
| Dexcom, Inc. | 4 | $535 |
| AstraZeneca | 5 | $514 |
| Abiomed | 5 | $502 |
| Actelion Pharmaceuticals US, Inc. | 4 | $476 |
| Neurocrine Biosciences, Inc. | 3 | $373 |
| Amgen | 3 | $353 |
| Sanofi | 3 | $324 |
| Corcept Therapeutics | 2 | $250 |
| Bayer | 3 | $235 |
| Insmed, Inc. | 2 | $211 |
| GSK | 2 | $210 |
| Sanofi-aventis U.S. LLC | 2 | $206 |
| Biohaven Pharmaceuticals, Inc. | 2 | $198 |
| Arcutis Biotherapeutics, Inc. | 2 | $186 |
| Idorsia Pharmaceuticals US Inc | 3 | $166 |
| Cvrx, Inc. | 1 | $138 |
| Teva Pharmaceuticals USA, Inc. | 1 | $133 |
| Boston Scientific | 1 | $129 |
| Verrica Pharmaceuticals Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $122 |
| Axonics, Inc. | 2 | $118 |
| Argenx US, Inc. | 1 | $116 |
| Alkermes, Inc. | 1 | $115 |
| Paratek Pharmaceuticals, Inc. | 1 | $114 |
| Sanofi Pasteur Inc. | 1 | $103 |
| Gilead | 1 | $103 |
| Boehringer Ingelheim | 1 | $101 |
| Lucid Diagnostics Inc. | 1 | $100 |
| Johnson & Johnson | 1 | $90 |
| Medtronic | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$535
- VRAYLAR$473
- LYBALVI$459
- UPTRAVI$393
- OPSUMIT$393
- FREESTYLE LIBRE 3$376
- INGREZZA$373
- DEXCOM STELO GLUCOSE BIOSENSOR$280
- Korlym$250
- UBRELVY$243
- Ozempic$241
- QULIPTA$236
- Impella$216
- Arikayce$211
- Wegovy$203
- FreeStyle Libre 2$145
- Barostim Neo System$138
- Austedo XR$133
- WATCHMAN FLX$129
- YCANTH$125
How this compares
$9,183 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other family in Clearwater
- Marian FinehirshClearwater$31K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.